These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
65 related articles for article (PubMed ID: 212566)
1. Nucleases and adenosine 3',5'-cyclic monophosphate phosphodiesterase activities in murine sarcoma virus (Moloney)-infected mice. Tsou KC; Lo KW; Herberman RB J Natl Cancer Inst; 1978 Oct; 61(4):1077-83. PubMed ID: 212566 [TBL] [Abstract][Full Text] [Related]
2. In vitro studies of cell-mediated immunity to Moloney murine leukemia virus and Moloney leukemia-associated surface antigens. Ng AK; Ames RS; McIntire RK; Herberman RB Cancer Res; 1979 Dec; 39(12):4887-93. PubMed ID: 387218 [TBL] [Abstract][Full Text] [Related]
3. Effect of cadmium exposure on primary tumor growth and cell-mediated cytotoxicity in mice bearing MSB sarcomas. Kerkvliet NI; Koller LD; Baecher LG; Brauner JA J Natl Cancer Inst; 1979 Aug; 63(2):479-83. PubMed ID: 287837 [TBL] [Abstract][Full Text] [Related]
4. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice. Menahan LA; Kemp RG J Cyclic Nucleotide Res; 1976; 2(6):417-25. PubMed ID: 190277 [TBL] [Abstract][Full Text] [Related]
5. Blocking of cell-mediated immunity to Moloney murine sarcoma virus-transformed cells by lactate dehydrogenase virus-antibody complex. McDonald TL J Natl Cancer Inst; 1983 Mar; 70(3):493-7. PubMed ID: 6572738 [TBL] [Abstract][Full Text] [Related]
6. Effects of growth conditions on cyclic nucleotide phosphodiesterases of cultured fibroblasts. Pledger WJ; Thompson J; Strada SJ J Cyclic Nucleotide Res; 1975; 1(6):251-9. PubMed ID: 178699 [TBL] [Abstract][Full Text] [Related]
7. Croton oil- and benzo(a)pyrene-induced changes in cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate phosphodiesterase activities in mouse epidermis. Verma AK; Froscio M; Murray AW Cancer Res; 1976 Jan; 36(1):81-7. PubMed ID: 174815 [TBL] [Abstract][Full Text] [Related]
8. Role of accessory cells in the induction of a secondary cytotoxic response to Moloney murine sarcoma virus-induced tumors. Biasi G; Saggin L; Dazzi F; De Rossi A; Collavo D J Immunol; 1983 Mar; 130(3):1447-50. PubMed ID: 6185589 [TBL] [Abstract][Full Text] [Related]
10. [Effect of irradiation and some sulfur containing compounds on 3':5'-cyclic AMP-phosphodiesterase activity of the tissue homogenates of experimental animals]. Zhivotova NI; Pushkareva NB; Filipovich IV; Romantsev EF Radiobiologiia; 1975; 15(5):726-30. PubMed ID: 174148 [No Abstract] [Full Text] [Related]
11. Tumor sponge implantation: an in vivo method for studying syngeneic, primary antitumor lymphocyte responses. Vallera DA; Mentzer SJ; Maizel SE Cancer Res; 1982 Feb; 42(2):397-404. PubMed ID: 7055792 [TBL] [Abstract][Full Text] [Related]
12. Antigenic specificities of the cellular immune response of C57BL/6 mice to the Moloney leukemia/sarcoma virus complex. Enjuanes L; Lee JC; Ihle JN J Immunol; 1979 Feb; 122(2):665-74. PubMed ID: 84033 [No Abstract] [Full Text] [Related]
13. Non-T-cell-mediated cytotoxicity in mice with tumors induced by Moloney murine sarcoma virus (M-MuSV). II. Granulocyte-mediatd cytotoxicity against autochthonous target cells isolated from M-MuSV-induced tumors. Becker S; Haskill S J Natl Cancer Inst; 1980 Aug; 65(2):469-75. PubMed ID: 6249952 [TBL] [Abstract][Full Text] [Related]
14. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6. White JB; Thompson WJ; Pittler SJ Mol Vis; 2004 Oct; 10():738-49. PubMed ID: 15480303 [TBL] [Abstract][Full Text] [Related]
15. Augmented immunogenicity of tumor cell membranes produced by infection with influenza virus as compared to Moloney sarcoma virus. Takeichi N; Austin FC; Oikawa T; Boone CW Cancer Res; 1978 Dec; 38(12):4580-4. PubMed ID: 214226 [TBL] [Abstract][Full Text] [Related]
16. T cell tolerance in moloney-murine leukemia virus (M-MuLV) carrier mice: low cytotoxic T lymphocyte precursor frequency and absence of suppressor T cells in carrier mice with Moloney-murine sarcoma (M-MSV)-induced tumors. Collavo D; Ronchese F; Zanovello P; Biasi G; Chieco-Bianchi L J Immunol; 1982 Feb; 128(2):774-9. PubMed ID: 6459385 [No Abstract] [Full Text] [Related]
17. Regulation of cell-mediated immunologic reactivity to Moloney Murine sarcoma virus-induced tumors. III. Further characterization of tumor-specific serum blocking factors. Halliday WJ; Koppi TA; McKenzie IF J Natl Cancer Inst; 1982 Oct; 69(4):939-44. PubMed ID: 6750199 [TBL] [Abstract][Full Text] [Related]